Donate now
11 November 2020

The International Collaboration for Cancer Classification and Research (IC3R): Translating research findings into clinical and diagnostic management

The International Agency for Research on Cancer (IARC) has launched a new website dedicated to the Agency’s International Collaboration for Cancer Classification and Research (IC3R). IC3R is a consortium of institutions created to address the challenges in translating research findings into clinical management by providing a forum for the coordination of evidence generation, synthesis, and evaluation, as well as for the promotion of standards and evidence-based practice for cancer classification and research.

Most countries have clear pathways for translating clinical trial results into practice through drug approval and clinical guidelines, but not always for the translation of evidence into tumour diagnosis.

IC3R’s areas of focus include harmonizing data in cancer research, identifying evidence gaps, setting standards, improving quality management and establishing best practices, updating the evidence, and addressing copyright considerations, with other activities to be added as consortium members identify additional needs.

Read IARC Press Release 290 

Visit the IC3R website 

Read the IC3R white paper 

Publication status

Published in section: IARC News

Publication date: 11 November, 2020, 0:56

Direct link:

© Copyright International Agency on Research for Cancer 2021
Close Reading Mode